AMPK磷酸化乙酰辅酶A羧化酶减少肾纤维化,且为二甲双胍抗纤维化作用所必需
研究在细胞和小鼠肾病模型中评估乙酰辅酶A羧化酶(ACC)磷酸化,发现肾损伤后ACC Ser79磷酸化降低促进肾小管间质纤维化(TIF)。在ACC磷酸化位点敲入突变小鼠中,脂质蓄积和纤维化加重,且二甲双胍抗纤维化作用消失甚至恶化纤维化,表明ACC磷酸化是二甲双胍抗纤维化所必需。
要点
- 肾损伤后肾小管上皮细胞ACC Ser79磷酸化降低,促进脂质蓄积和纤维化。
- ACC磷酸化位点突变小鼠在叶酸肾病和单侧输尿管梗阻模型中纤维化显著加重。
- 二甲双胍的抗纤维化作用依赖于ACC磷酸化,在突变小鼠中反而加重纤维化。
核心结论
- 肾损伤后ACC磷酸化降低促进肾小管间质纤维化。
- ACC磷酸化是二甲双胍肾脏抗纤维化作用所必需。
研究设计与样本
- 细胞模型:叶酸处理肾小管上皮细胞模拟细胞损伤。
- 小鼠模型:叶酸肾病模型和单侧输尿管梗阻模型,包括野生型(WT)和ACC磷酸化位点Ser-to-Ala敲入(KI)突变小鼠。
- 干预:二甲双胍给予WT和KI小鼠。
主要发现
- 叶酸处理的肾小管上皮细胞和叶酸肾病WT小鼠中ACC Ser79磷酸化降低。
- KI小鼠在叶酸肾病和单侧输尿管梗阻模型中脂质蓄积和纤维化较WT显著增加。
- 二甲双胍在WT小鼠中显著减少纤维化和脂质蓄积,但在KI小鼠中加重纤维化。
临床怎么用
- 二甲双胍的抗肾纤维化作用可能依赖于AMPK磷酸化ACC,需考虑ACC磷酸化状态。
- ACC磷酸化降低可能是肾小管间质纤维化的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Expression of genes regulating fatty acid metabolism is reduced in tubular epithelial cells from kidneys with tubulointerstitial fibrosis (TIF), thus decreasing the energy produced by fatty acid oxidation (FAO). Acetyl-CoA carboxylase (ACC), a target for the energy-sensing AMP-activating protein kinase (AMPK), is the major controller of the rate of FAO within cells. Metformin has a well described antifibrotic effect, and increases phosphorylation of ACC by AMPK, thereby increasing FAO. METHODS: We evaluated phosphorylation of ACC in cell and mouse nephropathy models, as well as the effects of metformin administration in mice with and without mutations that reduce ACC phosphorylation. RESULTS: Reduced phosphorylation of ACC on the AMPK site Ser79 occurred in both tubular epithelial cells treated with folate to mimic cellular injury and in wild-type (WT) mice after induction of the folic acid nephropathy model. When this effect was exaggerated in mice with knock-in (KI) Ser to Ala mutations of the phosphorylation sites in ACC, lipid accumulation and fibrosis increased significantly compared with WT. The effect of ACC phosphorylation on fibrosis was confirmed in the unilateral ureteric obstruction model, which showed significantly increased lipid accumulation and fibrosis in the KI mice. Metformin use was associated with significantly reduced fibrosis and lipid accumulation in WT mice. In contrast, in the KI mice, the drug was associated with worsened fibrosis. CONCLUSIONS: These data indicate that reduced phosphorylation of ACC after renal injury contributes to the development of TIF, and that phosphorylation of ACC is required for metformin's antifibrotic action in the kidney.
引用
- Lee M, Katerelos M, Gleich K, et al. Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin. J Am Soc Nephrol. 2018. PMID: 29976587. doi:10.1681/ASN.2018010050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。